SG11201912236YA - Crispr reporter non-human animals and uses thereof - Google Patents

Crispr reporter non-human animals and uses thereof

Info

Publication number
SG11201912236YA
SG11201912236YA SG11201912236YA SG11201912236YA SG11201912236YA SG 11201912236Y A SG11201912236Y A SG 11201912236YA SG 11201912236Y A SG11201912236Y A SG 11201912236YA SG 11201912236Y A SG11201912236Y A SG 11201912236YA SG 11201912236Y A SG11201912236Y A SG 11201912236YA
Authority
SG
Singapore
Prior art keywords
human animals
crispr reporter
reporter non
crispr
animals
Prior art date
Application number
SG11201912236YA
Inventor
Guochun Gong
Charleen Hunt
Susannah Brydges
Suzanne Hartford
David Frendewey
Brian Zambrowicz
Andrew J Murphy
Original Assignee
Regeneron Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Regeneron Pharma filed Critical Regeneron Pharma
Publication of SG11201912236YA publication Critical patent/SG11201912236YA/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/90—Stable introduction of foreign DNA into chromosome
    • C12N15/902—Stable introduction of foreign DNA into chromosome using homologous recombination
    • C12N15/907—Stable introduction of foreign DNA into chromosome using homologous recombination in mammalian cells
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/027—New or modified breeds of vertebrates
    • A01K67/0275—Genetically modified vertebrates, e.g. transgenic
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C12N15/861—Adenoviral vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/873—Techniques for producing new embryos, e.g. nuclear transfer, manipulation of totipotent cells or production of chimeric embryos
    • C12N15/877—Techniques for producing new mammalian cloned embryos
    • C12N15/8775—Murine embryos
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • C12N9/2468—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1) acting on beta-galactose-glycoside bonds, e.g. carrageenases (3.2.1.83; 3.2.1.157); beta-agarase (3.2.1.81)
    • C12N9/2471—Beta-galactosidase (3.2.1.23), i.e. exo-(1-->4)-beta-D-galactanase
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/07—Animals genetically altered by homologous recombination
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/20—Animal model comprising regulated expression system
    • A01K2217/206—Animal model comprising tissue-specific expression system, e.g. tissue specific expression of transgene, of Cre recombinase
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2227/00—Animals characterised by species
    • A01K2227/10—Mammal
    • A01K2227/105—Murine
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/03—Animal model, e.g. for test or diseases
    • A01K2267/0393—Animal model comprising a reporter system for screening tests
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/20—Type of nucleic acid involving clustered regularly interspaced short palindromic repeats [CRISPRs]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2320/00—Applications; Uses
    • C12N2320/10—Applications; Uses in screening processes
    • C12N2320/11—Applications; Uses in screening processes for the determination of target sites, i.e. of active nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01023—Beta-galactosidase (3.2.1.23), i.e. exo-(1-->4)-beta-D-galactanase

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Environmental Sciences (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Animal Husbandry (AREA)
  • Medicinal Chemistry (AREA)
  • Developmental Biology & Embryology (AREA)
  • Virology (AREA)
  • Cell Biology (AREA)
  • Mycology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
SG11201912236YA 2017-07-31 2018-07-31 Crispr reporter non-human animals and uses thereof SG11201912236YA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201762539279P 2017-07-31 2017-07-31
PCT/US2018/044606 WO2019028023A2 (en) 2017-07-31 2018-07-31 Methods and compositions for assessing crispr/cas-mediated disruption or excision and crispr/cas-induced recombination with an exogenous donor nucleic acid in vivo

Publications (1)

Publication Number Publication Date
SG11201912236YA true SG11201912236YA (en) 2020-01-30

Family

ID=63524355

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201912236YA SG11201912236YA (en) 2017-07-31 2018-07-31 Crispr reporter non-human animals and uses thereof

Country Status (12)

Country Link
US (2) US11021719B2 (en)
EP (1) EP3585160A2 (en)
JP (1) JP2020533957A (en)
KR (1) KR20200033259A (en)
CN (1) CN111182790A (en)
AU (1) AU2018309708A1 (en)
BR (1) BR112020001996A2 (en)
CA (1) CA3068072A1 (en)
IL (1) IL272333A (en)
MX (1) MX2020001177A (en)
SG (1) SG11201912236YA (en)
WO (1) WO2019028023A2 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG11201912236YA (en) 2017-07-31 2020-01-30 Regeneron Pharma Crispr reporter non-human animals and uses thereof
GB2589246A (en) * 2018-05-16 2021-05-26 Synthego Corp Methods and systems for guide RNA design and use
BR112021007229A2 (en) 2018-10-16 2021-08-10 Blueallele, Llc methods for targeted insertion of DNA into genes
CN109266680B (en) * 2018-10-17 2020-09-25 江苏集萃药康生物科技有限公司 Method for preparing CKO/KI animal model by using Cas9 technology
SG11202108090XA (en) * 2019-03-18 2021-08-30 Regeneron Pharma Crispr/cas dropout screening platform to reveal genetic vulnerabilities associated with tau aggregation
KR102264829B1 (en) 2019-11-22 2021-06-14 한국원자력의학원 Reporter System for Assessing Cleavage Activity of CRISPR/Cas9
CN112266931B (en) * 2020-10-15 2022-04-29 海湃泰克(北京)生物医药科技有限公司 Construction method and application of transgenic rat specifically expressing hMRGPRX4
WO2023064798A2 (en) * 2021-10-13 2023-04-20 The Board Of Trustees Of The Leland Stanford Junior University Differential proliferation of human hematopoietic stem and progenitor cells using truncated erythropoietin receptors
CN114703174B (en) * 2022-04-12 2023-10-24 中国科学院海洋研究所 CRISPR/Cas9 gene knockout method for rapidly obtaining genotype and phenotype mutation and application thereof
CN114703231B (en) * 2022-04-12 2023-10-24 中国科学院海洋研究所 Electroporation gene editing method and application of crassostrea gigas beta-tubulin gene

Family Cites Families (103)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4220093A (en) 1992-04-27 1993-11-29 Indiana University Foundation Live animal mutagenesis systems for testing mutagenic agents in vivo
US5523226A (en) 1993-05-14 1996-06-04 Biotechnology Research And Development Corp. Transgenic swine compositions and methods
AU8587598A (en) 1997-07-26 1999-02-16 Wisconsin Alumni Research Foundation Trans-species nuclear transfer
US20050144655A1 (en) 2000-10-31 2005-06-30 Economides Aris N. Methods of modifying eukaryotic cells
US6586251B2 (en) 2000-10-31 2003-07-01 Regeneron Pharmaceuticals, Inc. Methods of modifying eukaryotic cells
AUPR451401A0 (en) 2001-04-20 2001-05-24 Monash University A method of nuclear transfer
CA2474486C (en) 2002-01-23 2013-05-14 The University Of Utah Research Foundation Targeted chromosomal mutagenesis using zinc finger nucleases
AU2003218382B2 (en) 2002-03-21 2007-12-13 Sangamo Therapeutics, Inc. Methods and compositions for using zinc finger endonucleases to enhance homologous recombination
US7612250B2 (en) 2002-07-29 2009-11-03 Trustees Of Tufts College Nuclear transfer embryo formation method
AU2003298574B2 (en) 2002-09-05 2008-04-24 California Institute Of Technology Use of chimeric nucleases to stimulate gene targeting
US8409861B2 (en) 2003-08-08 2013-04-02 Sangamo Biosciences, Inc. Targeted deletion of cellular DNA sequences
US7888121B2 (en) 2003-08-08 2011-02-15 Sangamo Biosciences, Inc. Methods and compositions for targeted cleavage and recombination
US7972854B2 (en) 2004-02-05 2011-07-05 Sangamo Biosciences, Inc. Methods and compositions for targeted cleavage and recombination
US20060063231A1 (en) 2004-09-16 2006-03-23 Sangamo Biosciences, Inc. Compositions and methods for protein production
EP2767161B1 (en) 2004-10-19 2018-02-07 Regeneron Pharmaceuticals, Inc. Method for generating an non-human animal homozygous for a genetic modification
EP2447279B1 (en) 2006-05-25 2014-04-09 Sangamo BioSciences, Inc. Methods and compositions for gene inactivation
JP5266210B2 (en) 2006-05-25 2013-08-21 サンガモ バイオサイエンシズ インコーポレイテッド Modified cleavage half-domain
JP4692417B2 (en) 2006-06-30 2011-06-01 富士ゼロックス株式会社 Image forming apparatus
CN101117633B (en) 2006-08-03 2011-07-20 上海交通大学附属儿童医院 Nucleus transplantation method
ATE489465T1 (en) * 2007-04-26 2010-12-15 Sangamo Biosciences Inc TARGETED INTEGRATION INTO THE PPP1R12C POSITION
WO2008149176A1 (en) 2007-06-06 2008-12-11 Cellectis Meganuclease variants cleaving a dna target sequence from the mouse rosa26 locus and uses thereof
JP2011517838A (en) 2008-04-11 2011-06-16 ユーティーシー パワー コーポレイション Bipolar plate and fuel cell with manifold sump
JP5952263B2 (en) 2010-04-26 2016-07-13 サンガモ バイオサイエンシーズ， インコーポレイテッド Genome editing of the ROSA locus using zinc finger nuclease
CN103025344B (en) 2010-05-17 2016-06-29 桑格摩生物科学股份有限公司 Novel DNA-associated proteins and application thereof
SG10201811736QA (en) 2011-09-21 2019-02-27 Sangamo Therapeutics Inc Methods and compositions for regulation of transgene expression
WO2013063315A2 (en) 2011-10-27 2013-05-02 Sangamo Biosciences, Inc. Methods and compositions for modification of the hprt locus
US9637739B2 (en) 2012-03-20 2017-05-02 Vilnius University RNA-directed DNA cleavage by the Cas9-crRNA complex
WO2013141680A1 (en) 2012-03-20 2013-09-26 Vilnius University RNA-DIRECTED DNA CLEAVAGE BY THE Cas9-crRNA COMPLEX
SG11201406547YA (en) 2012-04-25 2014-11-27 Regeneron Pharma Nuclease-mediated targeting with large targeting vectors
ES2960803T3 (en) 2012-05-25 2024-03-06 Univ California Methods and compositions for RNA-directed modification of target DNA and for modulation of RNA-directed transcription
WO2014033644A2 (en) 2012-08-28 2014-03-06 Novartis Ag Methods of nuclease-based genetic engineering
ES2926021T3 (en) 2012-10-23 2022-10-21 Toolgen Inc Composition for cleaving a target DNA comprising a target DNA-specific guide RNA and Cas protein-encoding nucleic acid or Cas protein, and use thereof
EP3617309A3 (en) 2012-12-06 2020-05-06 Sigma Aldrich Co. LLC Crispr-based genome modification and regulation
SG10201912328UA (en) 2012-12-12 2020-02-27 Broad Inst Inc Delivery, Engineering and Optimization of Systems, Methods and Compositions for Sequence Manipulation and Therapeutic Applications
US8697359B1 (en) 2012-12-12 2014-04-15 The Broad Institute, Inc. CRISPR-Cas systems and methods for altering expression of gene products
IL308158A (en) 2012-12-17 2023-12-01 Harvard College Rna-guided human genome engineering
MX2015010841A (en) 2013-02-20 2016-05-09 Regeneron Pharma Genetic modification of rats.
EP2922393B2 (en) 2013-02-27 2022-12-28 Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH) Gene editing in the oocyte by cas9 nucleases
US9234213B2 (en) 2013-03-15 2016-01-12 System Biosciences, Llc Compositions and methods directed to CRISPR/Cas genomic engineering systems
US10119133B2 (en) * 2013-03-15 2018-11-06 The General Hospital Corporation Using truncated guide RNAs (tru-gRNAs) to increase specificity for RNA-guided genome editing
EP2981617B1 (en) 2013-04-04 2023-07-05 President and Fellows of Harvard College Therapeutic uses of genome editing with crispr/cas systems
DK2986729T3 (en) 2013-04-16 2018-10-29 Regeneron Pharma TARGETED MODIFICATION OF ROOT THROUGH
US20140349405A1 (en) 2013-05-22 2014-11-27 Wisconsin Alumni Research Foundation Rna-directed dna cleavage and gene editing by cas9 enzyme from neisseria meningitidis
AU2014281028B2 (en) 2013-06-17 2020-09-10 Massachusetts Institute Of Technology Delivery and use of the CRISPR-Cas systems, vectors and compositions for hepatic targeting and therapy
CA2915845A1 (en) 2013-06-17 2014-12-24 The Broad Institute, Inc. Delivery, engineering and optimization of systems, methods and compositions for targeting and modeling diseases and disorders of post mitotic cells
EP3011035B1 (en) 2013-06-17 2020-05-13 The Broad Institute, Inc. Assay for quantitative evaluation of target site cleavage by one or more crispr-cas guide sequences
CN106222197A (en) 2013-07-16 2016-12-14 中国科学院上海生命科学研究院 Plant Genome pointed decoration method
KR102407354B1 (en) 2013-09-23 2022-06-10 리제너론 파마슈티칼스 인코포레이티드 Non-human animals having a humanized signal-regulatory protein gene
US20160237455A1 (en) 2013-09-27 2016-08-18 Editas Medicine, Inc. Crispr-related methods and compositions
CN105899665B (en) 2013-10-17 2019-10-22 桑格摩生物科学股份有限公司 The delivering method and composition being transformed for nuclease-mediated genome project
RU2685914C1 (en) 2013-12-11 2019-04-23 Регенерон Фармасьютикалс, Инк. Methods and compositions for genome targeted modification
US9840699B2 (en) 2013-12-12 2017-12-12 President And Fellows Of Harvard College Methods for nucleic acid editing
CA2939942A1 (en) 2014-02-24 2015-08-27 Sangamo Biosciences, Inc. Methods and compositions for nuclease-mediated targeted integration
ES2898460T3 (en) 2014-02-27 2022-03-07 Monsanto Technology Llc Compositions and methods for site-directed genomic modification
WO2015179540A1 (en) 2014-05-20 2015-11-26 Regents Of The University Of Minnesota Method for editing a genetic sequence
WO2015191693A2 (en) 2014-06-10 2015-12-17 Massachusetts Institute Of Technology Method for gene editing
JP6930834B2 (en) 2014-06-16 2021-09-01 ザ・ジョンズ・ホプキンス・ユニバーシティー Compositions and Methods for Expression of CRISPR Guide RNA Using the H1 Promoter
EP3155099B1 (en) 2014-06-23 2018-03-21 Regeneron Pharmaceuticals, Inc. Nuclease-mediated dna assembly
US20150376586A1 (en) 2014-06-25 2015-12-31 Caribou Biosciences, Inc. RNA Modification to Engineer Cas9 Activity
ES2901074T3 (en) 2014-06-26 2022-03-21 Regeneron Pharma Methods and compositions for targeted genetic modifications and methods of use
EP2966170A1 (en) 2014-07-10 2016-01-13 Heinrich-Pette-Institut Leibniz-Institut für experimentelle Virologie-Stiftung bürgerlichen Rechts - HBV inactivation
EP3169309B1 (en) 2014-07-16 2023-05-10 Novartis AG Method of encapsulating a nucleic acid in a lipid nanoparticle host
US20160081314A1 (en) 2014-09-19 2016-03-24 Regeneron Pharmaceuticals, Inc. Chimeric Antigen Receptors
WO2016049024A2 (en) 2014-09-24 2016-03-31 The Broad Institute Inc. Delivery, use and therapeutic applications of the crispr-cas systems and compositions for modeling competition of multiple cancer mutations in vivo
TWI716367B (en) 2014-10-31 2021-01-21 麻省理工學院 Massively parallel combinatorial genetics for crispr
WO2016073990A2 (en) 2014-11-07 2016-05-12 Editas Medicine, Inc. Methods for improving crispr/cas-mediated genome-editing
NZ731962A (en) 2014-11-21 2022-07-01 Regeneron Pharma Methods and compositions for targeted genetic modification using paired guide rnas
WO2016089866A1 (en) 2014-12-01 2016-06-09 President And Fellows Of Harvard College Rna-guided systems for in vivo gene editing
MX2017008190A (en) * 2014-12-19 2018-03-23 Regeneron Pharma Methods and compositions for targeted genetic modification through single-step multiple targeting.
WO2016106236A1 (en) 2014-12-23 2016-06-30 The Broad Institute Inc. Rna-targeting system
EP3242938B1 (en) 2015-01-09 2020-01-08 Bio-Rad Laboratories, Inc. Detection of genome editing
CN107429263A (en) 2015-01-15 2017-12-01 斯坦福大学托管董事会 The method of controlling gene group editor
WO2016123514A1 (en) 2015-01-29 2016-08-04 University Of Massachusetts Nanoparticle-protein complex for intracellular protein delivery
WO2016132122A1 (en) 2015-02-17 2016-08-25 University Of Edinburgh Assay construct
US20180245073A1 (en) 2015-02-23 2018-08-30 Voyager Therapeutics, Inc. Regulatable expression using adeno-associated virus (aav)
WO2016176191A1 (en) 2015-04-27 2016-11-03 The Trustees Of The University Of Pennsylvania Dual aav vector system for crispr/cas9 mediated correction of human disease
US10179918B2 (en) 2015-05-07 2019-01-15 Sangamo Therapeutics, Inc. Methods and compositions for increasing transgene activity
US9790490B2 (en) 2015-06-18 2017-10-17 The Broad Institute Inc. CRISPR enzymes and systems
EP3159407A1 (en) 2015-10-23 2017-04-26 Silence Therapeutics (London) Ltd Guide rnas, methods and uses
CN106893739A (en) * 2015-11-17 2017-06-27 香港中文大学 For the new method and system of target gene operation
JP6997708B2 (en) 2015-11-20 2022-02-04 リジェネロン・ファーマシューティカルズ・インコーポレイテッド Non-human animal carrying the humanized LYMPHOCYTE-ACTIVATION GENE 3 gene
US10240145B2 (en) * 2015-11-25 2019-03-26 The Board Of Trustees Of The Leland Stanford Junior University CRISPR/Cas-mediated genome editing to treat EGFR-mutant lung cancer
EP3402884A1 (en) 2016-01-15 2018-11-21 Astrazeneca AB Gene modification assays
CN105647968B (en) 2016-02-02 2019-07-23 浙江大学 A kind of CRISPR/Cas9 working efficiency fast testing system and its application
KR102617874B1 (en) 2016-03-30 2023-12-22 인텔리아 테라퓨틱스, 인크. Lipid nanoparticle formulations for CRISPR/CAS components
CN116254231A (en) 2016-04-25 2023-06-13 巴塞尔大学 Allele editing and uses thereof
KR20170123581A (en) 2016-04-28 2017-11-08 연세대학교 산학협력단 Method for in vivo high-throughput evaluating of RNA-guided nuclease activity
IL267024B2 (en) 2016-12-08 2023-12-01 Intellia Therapeutics Inc MODIFIED GUIDE RNAs FOR GENOMIC EDITING
US20180185516A1 (en) 2016-12-09 2018-07-05 Sangamo Therapeutics, Inc. Delivery of target specific nucleases
CN110582302A (en) 2016-12-14 2019-12-17 利甘达尔股份有限公司 Compositions and methods for nucleic acid and/or protein payload delivery
US11060153B2 (en) 2016-12-22 2021-07-13 Yale University Fluorescence amplification method for forward genetic discovery of factors in human mRNA degradation
EP3625346A1 (en) 2017-05-16 2020-03-25 Cairn Biosciences, Inc. Multiplex assay
US11332749B2 (en) 2017-07-13 2022-05-17 Regents Of The University Of Minnesota Real-time reporter systems for monitoring base editing
CA3065579A1 (en) 2017-07-31 2019-02-07 Regeneron Pharmaceuticals, Inc. Assessment of crispr/cas-induced recombination with an exogenous donor nucleic acid in vivo
SG11201912236YA (en) 2017-07-31 2020-01-30 Regeneron Pharma Crispr reporter non-human animals and uses thereof
WO2019089761A1 (en) 2017-10-31 2019-05-09 The Broad Institute, Inc. Crispr protein inhibitors
WO2019089803A1 (en) 2017-10-31 2019-05-09 The Broad Institute, Inc. Methods and compositions for studying cell evolution
US20210123072A1 (en) 2018-04-20 2021-04-29 Dana-Farber Cancer Institute, Inc. Multifunctional nucleic acid reporter constructs
US11690921B2 (en) 2018-05-18 2023-07-04 Sangamo Therapeutics, Inc. Delivery of target specific nucleases
EP3802828A4 (en) 2018-06-08 2022-10-26 Intellia Therapeutics, Inc. Modified guide rnas for gene editing
WO2019246203A1 (en) 2018-06-19 2019-12-26 The Board Of Regents Of The University Of Texas System Lipid nanoparticle compositions for delivery of mrna and long nucleic acids
WO2020047531A1 (en) 2018-08-31 2020-03-05 The Children's Hospital Of Philadelphia Scalable tagging of endogenous genes by homology-independent intron targeting
WO2020146732A1 (en) 2019-01-11 2020-07-16 North Carolina State University Compositions and methods related to reporter systems and large animal models for evaluating gene editing technology

Also Published As

Publication number Publication date
US11021719B2 (en) 2021-06-01
RU2020105065A3 (en) 2021-11-10
MX2020001177A (en) 2020-09-25
CN111182790A (en) 2020-05-19
IL272333A (en) 2020-03-31
US20190032092A1 (en) 2019-01-31
CA3068072A1 (en) 2019-02-07
WO2019028023A3 (en) 2019-04-04
AU2018309708A1 (en) 2020-02-06
US20210261985A1 (en) 2021-08-26
EP3585160A2 (en) 2020-01-01
JP2020533957A (en) 2020-11-26
KR20200033259A (en) 2020-03-27
WO2019028023A4 (en) 2019-06-13
BR112020001996A2 (en) 2020-08-18
RU2020105065A (en) 2021-09-02
WO2019028023A2 (en) 2019-02-07

Similar Documents

Publication Publication Date Title
IL272333A (en) Crispr reporter non-human animals and uses thereof
PL3528608T3 (en) Planning and implementing agricultural measures
IL267319A (en) Livestock management
IL258006B (en) Automatically classifying animal behavior
SG11202002619YA (en) Insect breeding
FI3464628T3 (en) Target reporter constructs and uses thereof
IL269334A (en) Improved t cell compositions and methods
GB201707211D0 (en) Compositions and methods
ZA201903977B (en) Pet food compositions and methods for the same
GB2582718B (en) Fish farm
IL272859A (en) Ribociclib salts and solid state forms thereof
IL279059A (en) Sporicidal methods and compositions
IL264158A (en) Virucidal compounds and uses thereof
IL267184A (en) Phenylamidines and the use thereof as fungicides
NO20171271A1 (en) Fish Farm
IL261438A (en) Polymalic acid based nanoimmunoconjugates and uses thereof
SG11201706054QA (en) Enterovirus 71 animal model
IL267903A (en) Automated activity-time training
PL3197273T3 (en) Pesticide compositions and use thereof
IL267258A (en) Phenoxyphenylamidines and the use thereof as fungicides
ZA201807665B (en) Methods and compositions
GB201708888D0 (en) Forensic animal marking
GB201811622D0 (en) Weatherproof fan grill
GB201614897D0 (en) Compositions and uses thereof
ZA201901285B (en) Methods and compositions for modifying the behavior of animals